Mergers & Acquisitions ·
Universe Pharmaceuticals INC completed the acquisition of Best Praise International Limited on June 30, 2026
UPCUniverse Pharmaceuticals Inc
Universe Pharmaceuticals INC completed the acquisition of Best Praise International Limited on June 30, 2026. The company issued 4,376,552 Class A ordinary shares as full consideration for the target's five pharmaceutical patents related to age-related diseases and neurodegenerative conditions. Post-transaction, the issuer has 5,008,313 Class A and 16,077 Class B ordinary shares outstanding. Universe Pharmaceuticals INC operates in the pharmaceutical industry.